Key points from article :
Authorities in China have approved a drug for the treatment of Alzheimer's disease.
New drug is seaweed-based and it's called Oligomannate.
Oligomannate can be used for the treatment of mild to moderate Alzheimer's.
Sugar contained within seaweed suppresses certain bacteria contained in the gut.
Suppressed bacteria can cause neural degeneration and inflammation of the brain.
Oligomannate can statistically improve cognitive function among people with Alzheimer's in 4 weeks.
Green Valley pharmaceutical company will be bringing the new drug to the market.
Drug will be strictly monitored, even could be withdrawn if any safety issues arise.
